Financial Times
Nov 25, 2022 - 6 min
All in 1 subscription.
Is the drugs "renaissance" over? Although clinical trials have demonstrated the positive effects of psychedelics for mental health treatments, the industry still has a long way to go before it becomes mainstream. Hannah Devlin discovers how - despite the growing evidence of their potential - patients are being denied access to potentially life-saving drugs.